Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage
暂无分享,去创建一个
Aloke V. Finn | Renu Virmani | Allen P. Burke | R. Virmani | A. Finn | F. Kolodgie | H. Gold | J. Narula | A. Burke | S. Wrenn | Jagat Narula | Frank D. Kolodgie | Steven P. Wrenn | T. Tulenko | Herman K. Gold | Thomas N. Tulenko
[1] N. Rotllan,et al. Rapid Communication Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo , 2005 .
[2] Chun Yuan,et al. Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.
[3] M. Linton,et al. ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[4] M. Feldmann,et al. Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation? , 2004, Immunological reviews.
[5] Pathologic assessment of the vulnerable human coronary plaque , 2004, Heart.
[6] Gieri Cathomas,et al. Arterial Neovascularization and Inflammation in Vulnerable Patients: Early and Late Signs of Symptomatic Atherosclerosis , 2004, Circulation.
[7] A. Krettek,et al. Hypoxia Increases LDL Oxidation and Expression of 15-Lipoxygenase-2 in Human Macrophages , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[8] Amir Lerman,et al. Adventitial vasa vasorum heterogeneity among different vascular beds. , 2004, Journal of vascular surgery.
[9] S. Akira,et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Briscoe,et al. The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase1 , 2004, The Journal of Immunology.
[11] Alan W. Stitt,et al. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. , 2004, The American journal of pathology.
[12] M. Feldmann,et al. T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases. , 2004, Current drug targets. Inflammation and allergy.
[13] H. Üstün,et al. Cholesterol granuloma in the maxillary sinus , 2004, European Archives of Oto-Rhino-Laryngology.
[14] Renu Virmani,et al. Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.
[15] G. Camussi,et al. Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction 1 , 2003, The Journal of Immunology.
[16] S. W. Robertson,et al. Proangiogenic Function of CD40 Ligand-CD40 Interactions 12 , 2003, The Journal of Immunology.
[17] S. Vogel,et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.
[18] A. la Sala,et al. Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice , 2003, Circulation.
[19] R. Virmani,et al. 34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques? , 2003, Journal of the American College of Cardiology.
[20] G. Camussi,et al. CD40-dependent Activation of Phosphatidylinositol 3-Kinase/Akt Pathway Mediates Endothelial Cell Survival and in Vitro Angiogenesis* , 2003, The Journal of Biological Chemistry.
[21] David Zurakowski,et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] W. Cavenee,et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. , 2003, The American journal of pathology.
[23] Mark M. Kockx,et al. Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[24] D. Vance,et al. Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .
[25] Daniel Steinberg,et al. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime , 2002, Nature Medicine.
[26] J. Sluijter,et al. In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions , 2002, Circulation.
[27] M. Broncel,et al. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia , 2002, European Journal of Clinical Pharmacology.
[28] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[29] B. Cronstein,et al. Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. , 2002, The American journal of pathology.
[30] G. Hansson,et al. Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation , 2002, Circulation.
[31] M. Fishbein,et al. Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL , 2001, Circulation.
[32] R. Virmani,et al. The thin-cap fibroatheroma: a type of vulnerable plaque: The major precursor lesion to acute coronary syndromes , 2001, Current opinion in cardiology.
[33] R. Mofidi,et al. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease , 2001, The British journal of surgery.
[34] J. Guyton. Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins: a mechanism for atherogenic lipid accumulation. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[35] Holger Gerhardt,et al. Lack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis , 2001, The Journal of cell biology.
[36] M Shiomi,et al. Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits , 2001, Circulation.
[37] I. Tabas,et al. Cholesterol and phospholipid metabolism in macrophages. , 2000, Biochimica et biophysica acta.
[38] Stephen M. Schwartz,et al. Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[39] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[40] Robert V Farese,et al. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. , 2000, The Journal of clinical investigation.
[41] D. Mukhopadhyay,et al. Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. , 2000, Blood.
[42] K. Williams,et al. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[43] P. Yancey,et al. Crystallization of free cholesterol in model macrophage foam cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[44] D. Woolley,et al. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries , 1999, The Journal of pathology.
[45] P R Bell,et al. Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.
[46] R. Virmani,et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. , 1999, JAMA.
[47] P. Libby,et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. , 1999, The American journal of pathology.
[48] R. Virmani,et al. When neoangiogenesis ricochets. , 1998, American heart journal.
[49] W. Jacob,et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. , 1998, Circulation.
[50] R. Mason,et al. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis. , 1998, Journal of lipid research.
[51] E L Ritman,et al. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.
[52] M J Davies,et al. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[53] I. Tabas,et al. Evidence That the Initial Up-regulation of Phosphatidylcholine Biosynthesis in Free Cholesterol-loaded Macrophages Is an Adaptive Response That Prevents Cholesterol-induced Cellular Necrosis , 1996, The Journal of Biological Chemistry.
[54] S M Schwartz,et al. Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.
[55] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[56] G. Hansson,et al. Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.
[57] K. Rubin,et al. Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. , 1993, The American journal of pathology.
[58] Yixia Zhang,et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.
[59] A. Scanu,et al. Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages. , 1992, The Journal of biological chemistry.
[60] K. Bloch. Chapter 12 Cholesterol: evolution of structure and function , 1991 .
[61] D. Heistad,et al. Blood Flow through Vasa Vasorum of Coronary Arteries in Atherosclerotic Monkeys , 1986, Arteriosclerosis.
[62] P. Yeagle. Cholesterol and the cell membrane. , 1985, Biochimica et biophysica acta.
[63] M J Davies,et al. Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.
[64] M J Davies,et al. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. , 1984, The New England journal of medicine.
[65] A. Barger,et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.
[66] R. Gerrity,et al. The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.
[67] R. Virmani,et al. Pulmonary arteries in congenital heart disease: a structure-function analysis. , 1979, Cardiovascular clinics.
[68] G. Shipley,et al. Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. , 1976, The Journal of clinical investigation.
[69] V. Vancov. Structural basis of the microcirculation in the wall of arterial vessels. , 1973, Bibliotheca anatomica.
[70] I. Tannock,et al. The proliferation of capillary endothelial cells. , 1972, Cancer research.
[71] W. Wartman. Occlusion of the coronary arteries by hemorrhage into their walls , 1938 .